These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 23739328)
1. HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Cooper A; García M; Petrovas C; Yamamoto T; Koup RA; Nabel GJ Nature; 2013 Jun; 498(7454):376-9. PubMed ID: 23739328 [TBL] [Abstract][Full Text] [Related]
2. HIV integration and T cell death: additional commentary. Cooper A; García M; Petrovas C; Yamamoto T; Koup RA; Nabel GJ Retrovirology; 2013 Dec; 10():150. PubMed ID: 24321564 [TBL] [Abstract][Full Text] [Related]
3. HIV integrase and the swan song of the CD4 T cells? Estaquier J; Zaunders J; Laforge M Retrovirology; 2013 Dec; 10():149. PubMed ID: 24321528 [TBL] [Abstract][Full Text] [Related]
5. [Potential of integrase inhibitors to deplete HIV reservoirs or prevent their replenishment]. Llibre JM; Martínez-Picado J Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 12():17-22. PubMed ID: 19572421 [TBL] [Abstract][Full Text] [Related]
6. Nef expressed from human immunodeficiency virus type 1 extrachromosomal DNA downregulates CD4 on primary CD4+ T lymphocytes: implications for integrase inhibitors. Gillim-Ross L; Cara A; Klotman ME J Gen Virol; 2005 Mar; 86(Pt 3):765-771. PubMed ID: 15722538 [TBL] [Abstract][Full Text] [Related]
8. Pharmacovirological impact of an integrase inhibitor on human immunodeficiency virus type 1 cDNA species in vivo. Goffinet C; Allespach I; Oberbremer L; Golden PL; Foster SA; Johns BA; Weatherhead JG; Novick SJ; Chiswell KE; Garvey EP; Keppler OT J Virol; 2009 Aug; 83(15):7706-17. PubMed ID: 19458008 [TBL] [Abstract][Full Text] [Related]
9. A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs. Lassen KG; Hebbeler AM; Bhattacharyya D; Lobritz MA; Greene WC PLoS One; 2012; 7(1):e30176. PubMed ID: 22291913 [TBL] [Abstract][Full Text] [Related]
10. Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors. Surdo M; Cortese MF; Orlandi C; Di Santo F; Aquaro S; Magnani M; Perno CF; Casabianca A; Ceccherini-Silberstein F Antiviral Res; 2018 Dec; 160():165-174. PubMed ID: 30420339 [TBL] [Abstract][Full Text] [Related]
12. Single mutations in HIV integrase confer high-level resistance to raltegravir in primary human macrophages. Marsden MD; Avancena P; Kitchen CM; Hubbard T; Zack JA Antimicrob Agents Chemother; 2011 Aug; 55(8):3696-702. PubMed ID: 21628534 [TBL] [Abstract][Full Text] [Related]
13. Treatment with suboptimal doses of raltegravir leads to aberrant HIV-1 integrations. Varadarajan J; McWilliams MJ; Hughes SH Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14747-52. PubMed ID: 23959861 [TBL] [Abstract][Full Text] [Related]
14. Protein expression from unintegrated HIV-1 DNA introduces bias in primary in vitro post-integration latency models. Bonczkowski P; De Scheerder MA; Malatinkova E; Borch A; Melkova Z; Koenig R; De Spiegelaere W; Vandekerckhove L Sci Rep; 2016 Dec; 6():38329. PubMed ID: 27910923 [TBL] [Abstract][Full Text] [Related]
15. Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells. Saleh S; Wightman F; Ramanayake S; Alexander M; Kumar N; Khoury G; Pereira C; Purcell D; Cameron PU; Lewin SR Retrovirology; 2011 Oct; 8():80. PubMed ID: 21992606 [TBL] [Abstract][Full Text] [Related]
16. HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB. Saleh S; Lu HK; Evans V; Harisson D; Zhou J; Jaworowski A; Sallmann G; Cheong KY; Mota TM; Tennakoon S; Angelovich TA; Anderson J; Harman A; Cunningham A; Gray L; Churchill M; Mak J; Drummer H; Vatakis DN; Lewin SR; Cameron PU Retrovirology; 2016 Jul; 13(1):49. PubMed ID: 27459960 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of CD3/CD28-mediated activation of the MEK/ERK signaling pathway represses replication of X4 but not R5 human immunodeficiency virus type 1 in peripheral blood CD4(+) T lymphocytes. Popik W; Pitha PM J Virol; 2000 Mar; 74(6):2558-66. PubMed ID: 10684270 [TBL] [Abstract][Full Text] [Related]
18. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Buzón MJ; Massanella M; Llibre JM; Esteve A; Dahl V; Puertas MC; Gatell JM; Domingo P; Paredes R; Sharkey M; Palmer S; Stevenson M; Clotet B; Blanco J; Martinez-Picado J Nat Med; 2010 Apr; 16(4):460-5. PubMed ID: 20228817 [TBL] [Abstract][Full Text] [Related]
19. [Raltegravir: the first HIV integrase inhibitor. Introduction]. Gatell JM Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 12():1-2. PubMed ID: 19572418 [No Abstract] [Full Text] [Related]
20. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Doitsh G; Galloway NL; Geng X; Yang Z; Monroe KM; Zepeda O; Hunt PW; Hatano H; Sowinski S; Muñoz-Arias I; Greene WC Nature; 2014 Jan; 505(7484):509-14. PubMed ID: 24356306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]